scispace - formally typeset
K

Krishanthi Subramaniam

Researcher at University of Liverpool

Publications -  42
Citations -  2688

Krishanthi Subramaniam is an academic researcher from University of Liverpool. The author has contributed to research in topics: Medicine & Malaria. The author has an hindex of 19, co-authored 36 publications receiving 1558 citations. Previous affiliations of Krishanthi Subramaniam include Albert Einstein College of Medicine & Liverpool School of Tropical Medicine.

Papers
More filters
Journal ArticleDOI

Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

TL;DR: The identification of T cell responses associated with milder disease will support an understanding of protective immunity and highlights the potential of including non-spike proteins within future COVID-19 vaccine design.
Journal ArticleDOI

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

Clark D Russell, +355 more
TL;DR: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol UK (CCP-UK) study as discussed by the authors is an ongoing, prospective cohort study recruiting inpatients from 260 hospitals in England, Scotland, and Wales, conducted by the ISARIC Coronavirus Clinical Characterization Consortium.
Journal ArticleDOI

Implications of insecticide resistance for malaria vector control with long-lasting insecticidal nets: a WHO-coordinated, prospective, international, observational cohort study

TL;DR: Irrespective of resistance, populations in malaria endemic areas should continue to use long-lasting insecticidal nets to reduce their risk of infection and the development of additional vector control tools should be prioritised to reduce the unacceptably high malaria burden.
Journal ArticleDOI

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.

Chloe I Bloom, +339 more
TL;DR: In this paper, the effect of inhaled corticosteroid use in patients admitted to hospital with COVID-19 with underlying respiratory conditions was examined. But, the results were limited to patients aged 50 years and older and not for those with chronic pulmonary disease.
Journal ArticleDOI

The Absence of Serum IgM Enhances the Susceptibility of Mice to Pulmonary Challenge with Cryptococcus neoformans

TL;DR: A previously unrecognized role for IgM in resistance to intranasal infection with C. neoformans is established in mice and the mechanism by which it mediates a host benefit is by augmenting Th1 polarization, macrophage recruitment and phagocytosis of C. Neoformans.